baber/WOPTO huggingface dataset:
Patent EP-1066275-A1 (EP)
Inventor: CATINAT JEAN-PIERRE
IPC: C07D303/04
Filed: 1999-03-20
Abstract: Procédé continu de fabrication d'un oxiranne selon lequel on fait réagir dans un réacteur en phase liquide une oléfine avec un composé peroxydé en présence d'un catalyseur à base d'une zéolite et en présence d'un solvant, et on introduit en continu dans le réacteur un composé gazeux à un débit suffisant pour entraîner au moins une partie de l'oxiranne produit que l'on recueille avec le composé gazeux à l'endroit où celui-ci sort du réacteur.
Patent EP-1090992-A1 (EP)
Inventor: HONJO TASUKU
IPC: A61K38/00
Filed: 1999-04-28
Abstract: A novel human polypeptide. Because of having an effect of inhibiting
the proliferation of vascular smooth muscle cells, this polypeptid is
applicable to the treatment of diseases in which abnormal smooth muscle
proliferatoin participates, for example, arteriosclerosis and myeroma.
Moreover, this polypeptide has hematopoietic cell regulatory activity,
tissue forming/reparing activity, activin/inhibin activity,
chemotactic/chemokinetic activity, blood coagulating and thrombotic
activity, etc. Thus, it seems useful in preventing and/or treating various
diseases.
Patent EP-1084444-A1 (EP)
Inventor: TOMITA AKIRA
IPC: G02F1/13357
Filed: 1999-06-04
Abstract: La présente invention concerne un système d'imagerie à cristaux liquides, à réponse rapide et à contraste élevé. L'élément d'imagerie (901) utilise un composite de cristaux liquides (c'est à dire, constitué de cristaux liquides encapsulés) dont l'épaisseur est inférieure à 4 microns, et de préférence inférieure à 2,5 microns. L'élément d'imagerie est éclairé par au moins une source de lumière (903) placée de manière à faire un angle inférieur à 30 degrés par rapport à la normale à l'affichage. Le système de vision (1307) est placé du même côté de l'affichage que la source de lumière, de manière pratiquement normale à l'affichage. Dans une réalisation, le composite de cristaux liquides est soumis à un fonctionnement en mode inversé et une image virtuelle est créée. Dans une autre réalisation, au moins trois sources de lumière de couleurs différentes éclairent un élément d'imagerie à cristaux liquides. Les sources sont toutes placées à un angle faisant à peu près 30 degrés avec la normale à l'élément d'imagerie. Un microprocesseur (1311) est couplé à la fois aux sources de lumière (903) et à l'élément d'imagerie (901), ce qui permet ainsi de synchroniser les sources individuelles à lumière colorée avec la sortie de l'élément d'imagerie.
Patent EP-1102954-A1 (EP)
Inventor: VOIT JUERGEN
IPC: F25J3/04
Filed: 1999-08-05
Abstract: Removal of nitrous oxides in an air separation plant involves treatment of liquid, from the high-pressure column, in which it is concentrated. It is important to remove nitrous oxide, which has a comparatively high melting point, from the circuit before solid particles block the heat exchangers. This is done by occasionally purging the sump of high pressure column (6) at (16) and passing the liquid, which will contain all of the nitrous oxide, into a cleaning vessel (17) in which the nitrous oxide is removed by physical adsorption. Alternatively the purge liquid is warmed in a heat exchanger to a point where the nitrous oxide can be separated as a solid or liquid fraction. A counterflow material exchange method could also be used. The cleaned fluid then rejoins the process via line (18). The main flow of the oxygen enriched portion is removed at (13), at least one theoretical, or practical, floor (material exchange section (15)) above the air inlet (5), to continue the process in a conventional manner in the low-pressure column (7). Krypton and Xenon, also present in the sump liquid, can be concentrated and separated from the nitrous-oxide-free liquid leaving vessel (17). Methods for recovering cooling energy, involving further compression and conventional expansion through a turbine, are described.
Patent EP-1112057-A1 (EP)
Inventor: LINTNER KARL
IPC: A61K38/00
Filed: 1999-09-13
Abstract: The invention concerns the use of peptides of general sequence X-Thr-Thr-Lys-Y, wherein in particular X = lysine and Y = serine, in cosmetic or dermopharmaceutical compositions. It is moreover advantageous to use said peptides in mutual combination. In order to enhance their activity and their stability, the peptides are chemically modified to increase their lipophilicity, by grafting on the N-terminal amine of X, either a fatty acid chain, or by esterification or amidation of the C-terminal carboxyl group of Y. The peptides can be obtained by synthesis, biotechnology or controlled hydrolysis or plant proteins. The resulting compositions are advantageously used for stimulating healing, hydrating or all skin treatments. They are particularly active against formation or deterioration of wrinkles and against all the consequences of skin ageing, whether natural or induced (heliodermia, pollution), as well as for dry skin.
Patent EP-1121030-A1 (EP)
Inventor: BONCORAGLIO ANTONIO
IPC: A43B21/32
Filed: 1999-08-30
Abstract: We have invented a new sole with a pumping action for the part of the shoe near the heel, inside a cylindric pump, connected with channels near the front part of the foot connected to the outside part of the sole, with a valve for the passing of air. Therefore giving life and automatic movement of respiration and compression for the circulation of air for the inner part of the footwear, resolving all problems due to the loss of the circulation of air.
Patent EP-1121349-A1 (EP)
Inventor: THORWART WERNER
IPC: A61K31/445
Filed: 1999-10-02
Abstract: The invention relates to compounds of formula (I) which are used to produce drugs for prophylaxis and therapy of all conditions whose development is associated to an increased level of interleukin-1 beta , e.g. septic shock, leukaemia, hepatitis, amyotrophy, HIV infections or degenerative disorders of joints, such as arthrosis, spondylosis, chondrolysis following traumatic joint injury or prolonged immobilisation of joints following meniscus or knee cap injuries or ligament tears, or conjunctiva tissue conditions such as collagen disease, parodontium disease, wound healing disorders and chronic disease of the motility system, such as infectious, immunologic or metabolism-related acute and chronic arthritis, arthropathy, rheumatoid arthritis, myalgia and bone metabolism disorders.
Patent EP-1216154-A1 (EP)
Title: Procede d'impression a jet d'encre a meilleur entrelacement et appareils d'impression a cet effet
Inventor: MAYO RANDALL DAVID
IPC: G06K15/10
Filed: 1999-09-16
Abstract: L'invention concerne un procédé d'impression pour l'impression à jet d'encre sur un substrat d'enregistrement, qui repose sur l'utilisation d'une colonne de buses formant N points, servant à projeter l'encre sur une zone d'impression, N étant un entier supérieur à 2. La colonne de buses formant des points sont déplacées horizontalement sur la zone d'impression et dans chaque colonne de la zone d'impression, la tête d'impression dépose un ou plusieurs points à partir d'un sous-ensemble de buses formant S points, S étant un entier de 1 à N-1. Dans chaque colonne de la zone d'impression, pas plus d'une buse sur G buses dépose un point, et une buse dépose un point pas plus de toutes les G colonnes, G étant un entier compris entre 1 et S. Le sous-ensemble de buses formant S points est décalé verticalement parmi les buses formant N points dans au moins deux colonnes adjacentes selon un schéma préétabli. Le substrat d'enregistrement est avancé verticalement dans une première direction d'une hauteur équivalente à Q buses, Q équivalant à S/G. L'invention concerne également des appareils d'impression fonctionnant selon le présent procédé.
Patent EP-1034196-A1 (EP)
Inventor: LIPIAN JOHN-HENRY
IPC: C08F4/80
Filed: 1999-10-05
Abstract: Methods for the addition polymerization of cycloolefins using a cationic Group 10 metal complex and a weakly coordinating anion of the formula:wherein [(R')zM(L')x(L'')y] is a cation complex where M represents a Group 10 transition metal; R' represents an anionic hydrocarbyl containing ligand; L' represents a Group 15 neutral electron donor ligand; L'' represents a labile neutral electron donor ligand; x is 1 or 2; and y is 0, 1, 2, or 3; and z is 0 or 1, wherein the sum of x, y, and z is 4; and [WCA] represents a weakly coordinating counteranion complex; and b and d are numbers representing the number of times the cation complex and weakly coordinating counteranion complex are taken to balance the electronic charge on the overall catalyst complex.
Patent EP-1128788-A1 (EP)
Inventor: SPIERINGS PETRUS TARASIUS JOSE
IPC: A61F2/36
Filed: 1999-11-12
Abstract: A bone plug (61), for blocking of a canal in a bone, has a solid body which by axial compression expands in the radial direction. The height of the body is at most 6 times the average wall thickness of the body. The body (65) is preferably made out of an elastomeric material.For keeping the body (65) axially locked the bone plug comprises a first locking element (67) which is formed by a disc (69) with attached to it a stem (71) provided with saw tooth shaped protrusions (73) which protrudes through an axial opening in the body (65) and a second locking element (75) which is formed by an interrupted ring (77) and an annular plate (79), which are positioned around the stem (71). The ring (77) locks behind one of the protrusions (73) and the annular plate (79) is positioned between the interrupted ring (77) and the body (65).Fixating of the bone plug (61) in the canal is carried out by pushing the interrupted ring (77) along the stem (71) until it locks behind one of the protrusions.(73), whereby the body (65) is compressed between the plate (79) and the disc (69) and expands in radial direction and gets fixed in the bony canal.
Patent EP-1053095-A1 (EP)
Title: Appareil permettant de decouper et de plier un materiau en feuille
Inventor: CROFT RUSSELL F
IPC: B31B50/25
Filed: 1999-12-02
Abstract: L'invention concerne un appareil (10) permettant de fabriquer des prototypes d'emballages ou de boîtes destinés à contenir différents produits. Cet appareil comprend une surface de support servant à supporter un matériau en feuille (12) ainsi qu'un outil de découpe servant à découper dans le matériau en bande des lignes de contour de la boîte. La surface de support (32) comprend un évidement (34) dans laquelle s'insère une brosse (36). Pendant l'opération de découpe, l'outil de découpe (56) vient en contact avec la surface en brosse. Ainsi, lorsqu'il pénètre le matériau en feuille et qu'il vient en contact avec la surface en brosse (50), l'outil de découpe (56) ne s'émousse pas et n'endommage pas la surface en brosse (50). Par ailleurs, cette surface en brosse sert de support à une opération de pliage qui consiste à former, au moyen d'un outil de pliage, des lignes de pliage sur le matériau en feuille. Dans une variante, l'appareil selon l'invention comprend une surface rainurée interchangeable avec la brosse pour les opérations de pliage.
Patent EP-1140298-A1 (EP)
Title: Systeme de freinage pour patins a roues alignees
Inventor: NEUKAMP CHRISTINE
IPC: A63C17/14
Filed: 1999-12-23
Abstract: L'invention concerne des patins à roues alignées (1) comportant au moins une paire de roues (3) disposées en ligne, qui sont montées sur des axes (12), dans un châssis (2) en forme de U, ainsi qu'au moins une plaque de frein disposée sensiblement entre une surface intérieure des parois latérales et au moins un flanc des roues (3). Cette plaque de frein peut être pressée, de façon libérable, à l'aide d'un organe de déplacement, contre le flanc de roue correspondant. La ou les plaques de frein se présentent sous la forme d'un ressort à lame (4a) mince souple et élastique et s'étend sensiblement parallèlement à un flanc d'une ou de plusieurs roues (3).
Patent EP-1058953-A1 (EP)
Inventor: SCHUMANN HEIKO
IPC: H01R13/52
Filed: 1999-11-18
Abstract: Bei einer elektrischen Kontaktanordnung, mit zwei Kontakten, zwischen denen eine elektrisch leitende Verbindung besteht, wobei die Kontaktanordnung wasserdicht und staubdicht ist, und wobei die Kontakte in einem abgedichteten Raum angeordnet sind, schlägt die Erfindung vor, daß zur Abdichtung des abgedichteten Raums zwei Dichtungselemente im Abstand zueinander angeordnet sind, wobei zwischen den Dichtungselementen ein Prüfraum geschaffen ist, und wobei der Prüfraum eine von außen zugängliche Öffnung aufweist.
Patent EP-1134230-A1 (EP)
Inventor: ICHIMURA M
IPC: A61P25/28
Filed: 1999-11-19
Abstract: It is to provide agents for diagnosing, preventing
and treating a disease related to JNK3 cascade. 
     The present invention provides a novel polypeptide
JSAP which binds to JNK3, a production method of the
polypeptide, DNA encoding the polypeptide, a recombinant
DNA obtained by inserting the DNA into a vector, a
transformant comprising the recombinant vector, an antibody
recognizing the polypeptide, a determination method and
immunostaining method of the polypeptide of the present
invention using the antibody, a screening method using the
polypeptide, and agents for diagnosing, preventing and
treating a disease related to JNK3 cascade using the
polypeptide, the DNA or the antibody.
Patent FI-20175505-A1 (FI)
Title: Method of manufacturing a master plate and a master plate
Inventor: RAHOMÄKI JUSSI
IPC: G03F7/00
Filed: 2017-06-02
Abstract: The invention concerns a method of manufacturing a master plate for fabrication of diffractive structures, and a corresponding master plate. The method comprises providing a substrate (10) comprising a stack (12) of selective etch layers (12A-C, 14A-C) and providing an etch mask layer (16) on the substrate (10). Further, the method comprises etching the substrate (10) in a multi-step etching process by exposing the substrate (10) piecewise at different mask zones (S1-S5) of the mask layer (16) and using said selective etch layers (12A-C, 14A-C) to produce to the substrate (10) a height-modulated surface profile defined by the mask zones in lateral dimensions and by said stack (12) in height dimension of the substrate (10), and, finally, providing a height-modulated master grating (18') onto the surface profile, the height modulation of the master grating (18') being at least partly defined by said surface profile of the substrate (10).
Patent FI-20175681-A1 (FI)
Title: An instrument cassette for handling instruments
Inventor: VOLTTI GAIUS
IPC: G06K19/077
Filed: 2017-07-12
Abstract: An instrument cassette for handling instruments comprises a body section (101) for holding the instruments and a radio frequency identifier (102) readable from a distance away from the instrument cassette. The radio frequency identifier of the instrument cassette facilitates tracing operations, such as for example disinfection, sterilization, reparation, and clinical use, directed to or carried out with a set of instruments handled with the aid of the instrument cassette. The instruments can be for example medical and/or dental hand instruments.
Patent FI-20185309-A1 (FI)
Title: Optical measurement of inner diameter
Inventor: LASSILA ANTTI
IPC: G01N21/958
Filed: 2018-04-04
Abstract: A method (100) for optical measurement of a transparent tube (10), comprising directing a first collimated light beam (20a) from a first direction at the tube (10); directing a second collimated light beam (20b) from a second direction at the tube (10), wherein the first and second direction are at an angle to each other; receiving with a first detector element (30a) the light of the first light beam (20a) having passed through or about the tube (10); receiving with a second detector element (30b) the light of the second light beam (20b) having passed through or about the tube (10); and calculating an inner diameter (ID) of the tube (10) by detecting a shadow caused by the core of the tube (10) from a pattern received at the first and/or second detector element (30a,30b), respectively. Also an apparatus and a system for optical measurement as well as a method of manufacturing a transparent tube.
Patent FI-20195192-A1 (FI)
Title: A head restraint
Inventor: HEINO TUOMO
IPC: B64D11/06
Filed: 2019-03-14
Abstract: A head restraint for supporting head (10), comprising: a headband (13) configured to be worn by a user in a seated position; a seat fastener (11), configured to be fastened to an upper portion of a seat; a left outer strap (17) configured to connect a left side of the seat fastener (11) to a left side of the headband (13); and a right outer strap (14) configured to connect a right side of the seat fastener (11) to a right side of the headband (13). The head restraint comprises a left inner strap (15) configured to connect the left side of the seat fastener (11) to the right side of the headband (13); and a right inner strap (16) configured to connect the right side of the seat fastener (11) to the left side of the headband (13), wherein at least two out of four straps are in a tightened state when the user leans freely on the headband (13) in a seated position, said four straps being defined by the left outer strap (17), the left inner strap (15), the right outer strap (14) and the right inner strap (16).
Patent FI-20206181-A1 (FI)
Inventor: LEPPÄNEN JUHA
IPC: G06Q10/08
Filed: 2020-11-20
Abstract: Sovellusmuodot liittyvät järjestelmään (110), laitteisiin (200), menetelmiin (700, 800, 900) ja tietokoneohjelmiin (206) reseptiikan määrittämiseksi kovettuville seoksille. Järjestelmä (110) voi vastaanottaa saatavilla oleviin, kovettuvien tuotteiden valmistukseen soveltuviin, sivuvirtaperäisiin ja/tai neitseellisiin raaka-aineisiin liittyvää tietoa. Järjestelmä voi lisäksi vastaanottaa pyynnön kovettuvan lopputuotteen reseptiikan toimittamiseksi. Pyyntö voi sisältää lopputuotteen ominaisuustavoitetietoa. Järjestelmä (110) voi lisäksi määrittää reseptiikan pyynnönmukaiselle lopputuotteelle vastaanotetun ominaisuustavoitetiedon ja saatavilla oleviin raaka-aineisiin liittyvän tiedon perustella. Järjestelmä voi lisäksi tarjota erilliset käyttöliittymä- ja/tai tiedonsiirtorajapinnat (112, 114) raaka-aineiden tuottajille (120) ja lopputuotteiden valmistajille (130).
Patent HK-1024873-A1 (HK)
Title: Process for manufacturing a solid metroprolol composition.
Inventor: SETH PAWAN
IPC: A61P9/00
Filed: 2000-07-06
Abstract: A solid composition comprises: (a) 1-70 % metoprolol (M) in a non-amorphous form; (b) 10-95 % polyethylene oxide (PEO); and (c) a balance of conventional additives, excluding basic components. An Independent claim is also included for the preparation of the above composition, comprising: (i) mixing the dry state and the metoprolol (M) and the polyethylene oxide (PEO) and optionally one or more additives; (ii) optionally adding a solvent, followed by mixing; (iii) granulating the mixture; (iv) drying the granules; (v) optionally adding one or more additives with mixing in the dry state and passing it through a sieve; (vi) optionally adding one or more additives and mixing in the dry state; (vii) compressing the mixture obtained into a pressed tablet; and (viii) optionally coating the compressed tablet.
Patent HK-1032424-A1 (HK)
Title: Gram negative coccoid bacterium
Inventor: OKADA TAKAYUKI
IPC: C12N1/20
Filed: 2001-04-25
Abstract: A new gram negative coccoid bacterium, Okadaella gastrococcus is disclosed. The bacterium was isolated from an animal with a gastrointestinal disorder.
Patent HK-1033804-A1 (HK)
Title: Closure assembly for a drinking vessel
Inventor: ATKIN EDWARD
IPC: B65D47/20
Filed: 2001-05-15
Abstract: A closure assembly for a drinking vessel comprising a lid (2) with a spout (3). A diaphragm valve (14) is mounted on a central spigot (7) of an insert which protrudes from the bottom of the spout (3) and has an enlarged head (8) which provides a sealing surface (9) which cooperates with a bead (16) around a central hole (22) in the diaphragm. The diaphragm (14) has an annular flap (18) at its periphery which normally closes a breather hole (4) in the lid (2) but opens when a user sucks on the spout (3) to allow air to enter container (1) to equalize the internal and external pressure when liquid flows past the diaphragm (14).
Patent HK-1036803-A1 (HK)
Title: New camptothecin analogue compounds a process for their preparation and pharmaceutical compositions containing them.
Inventor: LAVIELLE GILBERT
IPC: C07D471/14
Filed: 2001-11-07
Abstract: Camptothecin analogs (I), their enantiomers, diastereoisomers, and salts with acids and bases are new. Camptothecin analogs of formula (I), their enantiomers, diastereoisomers, and salts are new. n = 0-2; R1-R5 = H, halogen, alkyl, alkenyl, alkynyl, perhaloalkyl, 3-11C cycloalkyl, 3-11C cycloalkyl-alkyl, OH, hydroxyalkyl, alkoxy, alkoxyalkyl, alkoxycarbonyl, acyloxy, NO2, CN, aminocarbonyl (optionally substituted on the N by one or two alkyl groups), -(CH2)p-NRaRb, or -O-CO- NRaRb; or two adjacent groups of R2-R5 = -O-(CH2)t-O-; p = 0 - 6; Ra, Rb = H, alkyl, 3-11C cycloalkyl, 3-11C cycloalkyl-alkyl, acyl, optionally substituted aryl or optionally substituted arylalkyl; or NRaRb = pyrrolyl, piperidinyl, or piperazinyl each of the cyclic groups being optionally substituted; t = 1-3; R60, R70n, R80, and R90 = H, OH, alkoxy, or -O-CO-X or -O-CO-NXW; X, W = alkyl, alkenyl, alkynyl, 3-11C cycloalkyl, 3-11C cycloalkyl-alkyl, optionally substituted aryl, or optionally substituted aryl alkyl; R61, R71n, R81, and R91 = H, alkyl, alkenyl or alkynyl; or vicinal pairs may together form a bond or an oxirane group; or R60+R61, R70n+R71n, R80+R81n and/or R90+R91 = oxo or -O-(CH2)t1-O-; t1 = 1-3 with the proviso that R60, R70n, R80, R90, R61, R71n, R81, and R91 are not all H. Alkyl, alkoxy and acyl groups have 1-6C; alkenyl have 2-6C and 1-3 double bonds; alkynyl have 2-6C and 1-3 triple bonds; aryl = phenyl or naphthyl; 'substituted' on aryl or aryl alkyl groups means by one or more halogens, alkyl, alkoxy, OH, CN, NO2, amino or mono- or dialkylamino groups; 'substituted' on heterocyclic groups means by one or more alkyl, alkoxy, aryl, aryl alkyl, aryloxy and/or aryloxy alkyl groups. An Independent claim is included for the preparation of (I).
Patent HK-1044566-A1 (HK)
Title: Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use
Inventor: HABERMANN PAUL
IPC: C12N9/48
Filed: 2002-08-22
Abstract: Pancreatic carboxypeptidase B or an isoform or a mutein of carboxypeptidase B may be prepared by (a) expressing a natural or unnatural enzymatically inactive precursor form of carboxypeptidase B in a microorganism by secretion, (b) purifying the precursor form expressed by secretion, and (c) converting the purified precursor form into the active form by an enzymatic treatment. A nucleic acid construct and a host cell containing the construct are useful for preparing pancreatic carboxypeptidase B or an isoform or a mutein thereof by this method.
Patent HK-1046379-A1 (HK)
Title: Mixture for the treatment of waste materials
Inventor: SCHWETLICK WOLFGANG
IPC: A62D3/33
Filed: 2002-11-01
Abstract: The invention relates to a mixture and a process for the treatment of waste materials and the use of the mixture for the treatment of waste materials and waste material treated therewith. The mixture comprises (A) at least one zinc salt of a saturated or unsaturated aliphatic or aromatic carboxylic acid, (B) at least one calcium salt of a saturated or unsaturated aliphatic or aromatic carboxylic acid, (C) at least one hydrophobing agent, (D) at least one amino alcohol and (E) NH<SUB>3</SUB>.
Patent HK-1050211-A1 (HK)
Title: Recombinant adenoviruses preparation and adenovirus banks
Inventor: ROBERT JEAN-JACQUES
IPC: C12Q1/68
Filed: 2003-01-24
Abstract: The invention concerns compositions and methods for preparing recombinant adenoviruses. The resulting adenoviruses can be used for transferring and/or expressing genes in cells, in vitro, ex vivo or in vivo, or also in functional genomics. More particularly, the invention concerns in particular efficient methods for producing adenovirus banks and the use of said banks in functional genomics. The invention also concerns plasmids used for constructing said adenoviruses.